IL-7 not only increases the number of T cells directed against SARS-CoV-2 viral antigens but also increases T cell receptor diversity, thereby potentially enhancing the intensity of the T cell response and lowering the risk of secondary infections (30, 32, 50). The gene discussed is IL7; the disease is infection.